Overcoming Anti-PD-1 Resistance: Targeted STING Activation Reprograms Tumor-Associated Macrophages
Anti-PD-1 immunotherapy has limited response rates in various solid tumors, and the immunosuppressive microenvironment mediated by tumor-associated macrophages (TAMs) is a key factor leading to resistance. This study aims to explore whether targeting and activating the STING pathway can reprogram TAMs to reverse resist...